# WIA-ALZHEIMERS - Phase 4: Integration

> **Version:** 1.0.0
> **Last Updated:** 2025-12-29
> **Status:** Complete
> **Standard ID:** WIA-MED-ALZHEIMERS

---

## 1. Overview

Phase 4 defines the system integration standards for WIA-ALZHEIMERS, enabling seamless connectivity with electronic health records (EHR), laboratory information systems, imaging platforms, wearable devices, and the broader WIA ecosystem. This phase ensures that NAD+ homeostasis-based Alzheimer's assessment can be deployed universally across healthcare settings.

### 1.1 Integration Goals

1. **Universal Interoperability**: Connect with any healthcare system worldwide
2. **Data Portability**: Enable patient data to follow the patient
3. **Real-time Monitoring**: Support continuous health tracking
4. **Research Enablement**: Facilitate large-scale studies through standardized data

---

## 2. Healthcare Standards Compatibility

### 2.1 FHIR R5 Integration

The WIA-ALZHEIMERS standard is fully compatible with HL7 FHIR R5. All data elements map to standard FHIR resources.

#### 2.1.1 Resource Mappings

| WIA-ALZHEIMERS | FHIR Resource | Notes |
|----------------|---------------|-------|
| NAD+ Homeostasis Index | Observation | Custom code system |
| Pathology Profile | DiagnosticReport | Bundle of Observations |
| Cognitive Assessment | Observation | LOINC codes |
| Biomarkers | Observation | LOINC/SNOMED codes |
| Treatment Response | MedicationStatement + Observation | Linked resources |
| Subject | Patient | Demographics |
| Intervention | MedicationRequest | Treatment orders |

#### 2.1.2 NAD+ Homeostasis as FHIR Observation

```json
{
  "resourceType": "Observation",
  "id": "nad-homeostasis-001",
  "meta": {
    "profile": ["https://wia.live/fhir/StructureDefinition/NADHomeostasisIndex"]
  },
  "status": "final",
  "category": [{
    "coding": [{
      "system": "http://terminology.hl7.org/CodeSystem/observation-category",
      "code": "laboratory",
      "display": "Laboratory"
    }]
  }],
  "code": {
    "coding": [{
      "system": "https://wia.live/codes/alzheimers",
      "code": "NAD-HOMEOSTASIS-INDEX",
      "display": "NAD+ Homeostasis Index"
    }]
  },
  "subject": {
    "reference": "Patient/patient-001"
  },
  "effectiveDateTime": "2025-12-29T10:30:00Z",
  "valueQuantity": {
    "value": 0.72,
    "unit": "index",
    "system": "https://wia.live/units",
    "code": "homeostasis-index"
  },
  "interpretation": [{
    "coding": [{
      "system": "https://wia.live/codes/interpretation",
      "code": "good",
      "display": "Good"
    }]
  }],
  "component": [
    {
      "code": {
        "coding": [{
          "system": "https://wia.live/codes/alzheimers",
          "code": "NAD-PLUS",
          "display": "NAD+ Concentration"
        }]
      },
      "valueQuantity": {
        "value": 28.5,
        "unit": "μM",
        "system": "http://unitsofmeasure.org",
        "code": "umol/L"
      }
    },
    {
      "code": {
        "coding": [{
          "system": "https://wia.live/codes/alzheimers",
          "code": "NADH-NAD-RATIO",
          "display": "NADH/NAD+ Ratio"
        }]
      },
      "valueQuantity": {
        "value": 0.18,
        "unit": "ratio"
      }
    }
  ]
}
```

#### 2.1.3 Cognitive Assessment Bundle

```json
{
  "resourceType": "Bundle",
  "type": "collection",
  "entry": [
    {
      "resource": {
        "resourceType": "Observation",
        "code": {
          "coding": [{
            "system": "http://loinc.org",
            "code": "72106-8",
            "display": "Total score [MMSE]"
          }]
        },
        "valueInteger": 24
      }
    },
    {
      "resource": {
        "resourceType": "Observation",
        "code": {
          "coding": [{
            "system": "http://loinc.org",
            "code": "72172-0",
            "display": "Total score [MoCA]"
          }]
        },
        "valueInteger": 22
      }
    },
    {
      "resource": {
        "resourceType": "Observation",
        "code": {
          "coding": [{
            "system": "http://loinc.org",
            "code": "88689-2",
            "display": "CDR Sum of boxes"
          }]
        },
        "valueQuantity": {
          "value": 2.5,
          "unit": "score"
        }
      }
    }
  ]
}
```

### 2.2 HL7v2 Integration

For legacy systems, WIA-ALZHEIMERS supports HL7v2 message exchange.

#### 2.2.1 ORU (Observation Result) Message

```
MSH|^~\&|WIA-ALZHEIMERS|WIA|EHR|HOSPITAL|20251229103000||ORU^R01|MSG001|P|2.5.1
PID|1||PATIENT001^^^WIA||DOE^JANE||19570315|F
OBR|1|ORD001|RES001|NAD-HOME^NAD+ Homeostasis Index^WIA|||20251229103000
OBX|1|NM|NAD-INDEX^Homeostasis Index^WIA||0.72|index|0.70-1.00|N|||F
OBX|2|NM|NAD-PLUS^NAD+ Concentration^WIA||28.5|uM|20-40|N|||F
OBX|3|NM|NADH-RATIO^NADH/NAD+ Ratio^WIA||0.18|ratio|0.10-0.30|N|||F
OBX|4|CE|INTERP^Interpretation^WIA||GOOD^Good^WIA|||N|||F
```

#### 2.2.2 ADT (Patient Demographics)

```
MSH|^~\&|ADT|EHR|WIA-ALZHEIMERS|WIA|20251229103000||ADT^A01|MSG002|P|2.5.1
PID|1||PATIENT001^^^WIA||DOE^JANE||19570315|F|||123 MAIN ST^^CITY^ST^12345||555-1234
DG1|1||G30.9^Alzheimer's disease, unspecified^ICD10|||A
```

### 2.3 CDA (Clinical Document Architecture)

```xml
<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3">
  <templateId root="2.16.840.1.113883.10.20.22.1.1"/>
  <code code="NAD-ASSESSMENT" codeSystem="2.16.840.1.113883.6.1"
        displayName="NAD+ Homeostasis Assessment"/>
  <title>WIA-ALZHEIMERS Assessment Report</title>
  <effectiveTime value="20251229103000"/>

  <component>
    <structuredBody>
      <component>
        <section>
          <templateId root="2.16.840.1.113883.10.20.22.2.3.1"/>
          <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"
                displayName="Results"/>
          <title>NAD+ Homeostasis Index</title>
          <entry>
            <observation classCode="OBS" moodCode="EVN">
              <code code="NAD-INDEX" codeSystem="https://wia.live/codes"/>
              <value xsi:type="PQ" value="0.72" unit="index"/>
              <interpretationCode code="GOOD"/>
            </observation>
          </entry>
        </section>
      </component>
    </structuredBody>
  </component>
</ClinicalDocument>
```

---

## 3. EHR Integration

### 3.1 Epic Integration

#### 3.1.1 SMART on FHIR App

WIA-ALZHEIMERS provides a SMART on FHIR application for Epic integration.

**Registration:**
```json
{
  "client_name": "WIA-ALZHEIMERS Assessment",
  "client_id": "wia-alzheimers-epic",
  "redirect_uris": ["https://app.wia.live/callback"],
  "scope": "launch/patient patient/*.read patient/*.write",
  "token_endpoint_auth_method": "private_key_jwt"
}
```

**Launch Sequence:**
1. Epic launches WIA-ALZHEIMERS app from patient chart
2. App receives authorization code
3. App exchanges code for access token
4. App reads patient data via FHIR API
5. App writes assessment results back to Epic

#### 3.1.2 Epic Flowsheets Integration

Custom flowsheet rows for NAD+ tracking:

| Flowsheet Row | Epic ID | Data Type | Units |
|---------------|---------|-----------|-------|
| NAD+ Level | WIA001 | Numeric | μM |
| NADH/NAD+ Ratio | WIA002 | Numeric | ratio |
| Homeostasis Index | WIA003 | Numeric | index |
| Interpretation | WIA004 | Text | - |

### 3.2 Cerner (Oracle Health) Integration

#### 3.2.1 Millennium Integration

**PowerChart Component:**
```javascript
// MPage component for NAD+ display
CERN_PLATFORM.registerComponent({
  name: "WIA_ALZHEIMERS_NAD",
  container: "patient_chart",
  dataSource: {
    type: "FHIR",
    endpoint: "/Observation?code=NAD-HOMEOSTASIS-INDEX",
    patient: "${patient_id}"
  },
  render: function(data) {
    return `
      <div class="wia-nad-widget">
        <h3>NAD+ Homeostasis</h3>
        <div class="score">${data.homeostasis_index}</div>
        <div class="interpretation">${data.interpretation}</div>
      </div>
    `;
  }
});
```

### 3.3 MEDITECH Integration

**MAT (Medical Administration Terminal) Interface:**
```
SEGMENT: RESULT
  PATIENT: ${patient_id}
  TEST: NAD-HOMEOSTASIS
  VALUE: 0.72
  UNITS: index
  RANGE: 0.70-1.00
  FLAG: NORMAL
  DATETIME: 2025-12-29 10:30:00
END-SEGMENT
```

---

## 4. Laboratory Integration

### 4.1 LIS (Laboratory Information System) Connectivity

#### 4.1.1 Quest Diagnostics

**Order Interface:**
```json
{
  "order": {
    "test_code": "WIA-NAD-PANEL",
    "patient_id": "QD12345678",
    "collection_date": "2025-12-29",
    "specimens": ["plasma_edta"],
    "tests": [
      "NAD_PLUS",
      "NADH",
      "NMN",
      "NICOTINAMIDE"
    ]
  }
}
```

**Result Interface:**
```json
{
  "results": {
    "order_id": "ORD789",
    "completed_date": "2025-12-30",
    "tests": [
      {
        "code": "NAD_PLUS",
        "value": 28.5,
        "unit": "μM",
        "reference_range": "20-40",
        "flag": "N"
      },
      {
        "code": "NADH",
        "value": 5.1,
        "unit": "μM",
        "reference_range": "2-8",
        "flag": "N"
      }
    ]
  }
}
```

#### 4.1.2 LabCorp Integration

Similar interface with LabCorp-specific codes and routing.

#### 4.1.3 Research Laboratory Integration

For specialized NAD+ and biomarker assays:

**Supported Platforms:**
- Quanterix Simoa HD-X (plasma biomarkers)
- Fujirebio Lumipulse (CSF and plasma)
- Waters HPLC-MS/MS (NAD+ metabolites)
- Agilent LC-MS (comprehensive metabolomics)

### 4.2 Biobank Integration

**Sample Registration:**
```json
{
  "sample_id": "BIO-2025-001234",
  "subject_id": "patient-001",
  "sample_type": "plasma",
  "collection_date": "2025-12-29T08:00:00Z",
  "volume_ml": 5,
  "storage": {
    "location": "Freezer-A-Rack-3-Box-12-Position-45",
    "temperature": -80,
    "aliquots": 10
  },
  "wia_alzheimers": {
    "linked_assessment": "asmt_123456",
    "consent_research": true
  }
}
```

---

## 5. Imaging Integration

### 5.1 PACS (Picture Archiving and Communication System)

**DICOM Integration:**

```
(0008,0016) SOP Class UID: 1.2.840.10008.5.1.4.1.1.128 (PET Image Storage)
(0008,0060) Modality: PT
(0008,103E) Series Description: Amyloid PET - Florbetapir
(0010,0020) Patient ID: PATIENT001
(0018,1074) Radionuclide Total Dose: 370 MBq
(0054,1001) Units: BQML
```

**WIA-ALZHEIMERS Metadata Extension:**
```json
{
  "private_creator": "WIA-ALZHEIMERS",
  "elements": {
    "(7FE1,0010)": {
      "vr": "DS",
      "name": "Centiloid Value",
      "value": "45.2"
    },
    "(7FE1,0011)": {
      "vr": "CS",
      "name": "Amyloid Status",
      "value": "POSITIVE"
    }
  }
}
```

### 5.2 Imaging AI Integration

**Volumetric Analysis Results:**
```json
{
  "analysis_id": "VOL-2025-001",
  "software": "FreeSurfer 7.4",
  "structures": {
    "left_hippocampus": {
      "volume_mm3": 3245,
      "percentile": 32,
      "z_score": -1.2
    },
    "right_hippocampus": {
      "volume_mm3": 3156,
      "percentile": 28,
      "z_score": -1.4
    },
    "total_brain_volume": {
      "volume_mm3": 1125000,
      "atrophy_percent": 8.5
    }
  },
  "ad_signature_thickness": {
    "value": 2.45,
    "unit": "mm",
    "status": "borderline"
  }
}
```

---

## 6. Wearable Device Integration

### 6.1 Sleep Tracking

**Oura Ring / Whoop Integration:**
```json
{
  "device": "oura_ring_gen3",
  "date": "2025-12-28",
  "sleep_data": {
    "total_sleep_minutes": 432,
    "deep_sleep_minutes": 95,
    "rem_sleep_minutes": 112,
    "light_sleep_minutes": 225,
    "awake_minutes": 18,
    "efficiency_percent": 87,
    "latency_minutes": 12,
    "hrv_average": 42
  },
  "wia_alzheimers_relevance": {
    "glymphatic_clearance_window": "adequate",
    "sleep_quality_score": 0.82,
    "recommendation": "Maintain current sleep patterns"
  }
}
```

### 6.2 Activity Monitoring

**Apple Watch / Fitbit Integration:**
```json
{
  "device": "apple_watch_ultra",
  "date": "2025-12-28",
  "activity_data": {
    "steps": 8542,
    "active_minutes": 45,
    "exercise_minutes": 32,
    "standing_hours": 10,
    "calories_active": 385,
    "vo2_max": 32.5
  },
  "wia_alzheimers_relevance": {
    "aerobic_threshold_met": true,
    "nad_boost_potential": "moderate",
    "weekly_exercise_goal_progress": 0.65
  }
}
```

### 6.3 Cognitive Apps

**Lumosity / BrainHQ Integration:**
```json
{
  "platform": "lumosity",
  "session_date": "2025-12-28",
  "games_played": [
    {
      "name": "Memory Matrix",
      "category": "memory",
      "score": 12450,
      "percentile": 68
    },
    {
      "name": "Speed Match",
      "category": "speed",
      "score": 8920,
      "percentile": 72
    }
  ],
  "cognitive_indices": {
    "memory": 105,
    "attention": 98,
    "flexibility": 102,
    "speed": 112,
    "problem_solving": 95
  },
  "wia_correlation": {
    "cognitive_trend": "stable",
    "confidence": 0.75
  }
}
```

---

## 7. WIA Ecosystem Integration

### 7.1 Cross-Standard Interoperability

WIA-ALZHEIMERS integrates with other WIA standards:

| Related Standard | Integration Point | Data Exchange |
|------------------|-------------------|---------------|
| WIA-LONGEVITY | NAD+ metabolism | Shared biomarkers |
| WIA-BRAIN-INTERFACE | Cognitive metrics | Assessment data |
| WIA-GENETICS | APOE genotyping | Risk stratification |
| WIA-TELEMEDICINE | Remote monitoring | Video consultations |

### 7.2 WIA Registry

**Global Patient Registry:**
```json
{
  "registry_entry": {
    "wia_id": "WIA-AD-2025-001234",
    "created": "2025-12-29",
    "consent_level": "full_research",
    "data_sharing": {
      "clinical": true,
      "research": true,
      "anonymized_global": true
    },
    "certifications": [
      {
        "level": 2,
        "granted": "2025-12-29",
        "valid_until": "2026-12-29"
      }
    ]
  }
}
```

---

## 8. Certification Requirements

### 8.1 Four-Level Certification

| Level | Name | Requirements | Use Case |
|-------|------|--------------|----------|
| 1 | Basic Screening | Plasma NAD+, MMSE/MoCA, Aβ42/40 | Primary care screening |
| 2 | Comprehensive | Full NAD+ index, p-tau, MRI volumetrics | Specialty clinics |
| 3 | Precision | CSF biomarkers, PET, enzyme profiles | Memory centers |
| 4 | Research | 12+ month tracking, omics, tissue samples | Clinical trials |

### 8.2 Certification Process

1. **Application**: Submit via WIA portal
2. **Assessment**: Review of capabilities and protocols
3. **Validation**: Test data exchange with WIA systems
4. **Audit**: On-site or remote verification
5. **Certification**: Badge and registry listing

### 8.3 Compliance Badges

```html
<!-- Level 2 Certification Badge -->
<a href="https://cert.wia.live/verify/AD-CERT-2025-001">
  <img src="https://wia.live/badges/alzheimers-l2.svg"
       alt="WIA-ALZHEIMERS Level 2 Certified"
       width="150" height="50">
</a>
```

---

## 9. Data Governance

### 9.1 Privacy Compliance

**HIPAA (US):**
- PHI encryption in transit (TLS 1.3) and at rest (AES-256)
- Minimum necessary access principle
- Audit logging of all data access
- Business Associate Agreements required

**GDPR (EU):**
- Data Subject Rights implementation
- Consent management system
- Data Processing Agreements
- 72-hour breach notification

**Local Regulations:**
- Japan: APPI compliance
- China: PIPL compliance
- Brazil: LGPD compliance

### 9.2 Consent Management

```json
{
  "consent_record": {
    "subject_id": "patient-001",
    "consent_date": "2025-12-01",
    "consents": {
      "clinical_care": {
        "granted": true,
        "scope": "full"
      },
      "research_identified": {
        "granted": true,
        "scope": "ad_studies_only"
      },
      "research_anonymized": {
        "granted": true,
        "scope": "global"
      },
      "commercial_use": {
        "granted": false
      },
      "genetic_analysis": {
        "granted": true,
        "scope": "apoe_only"
      }
    },
    "withdrawal_option": "https://wia.live/consent/withdraw"
  }
}
```

### 9.3 Data Anonymization

For research data sharing:

**K-Anonymity (k≥5):**
- Age generalized to 5-year ranges
- Geographic data generalized to region
- Dates shifted by random offset

**Differential Privacy:**
- Epsilon = 1.0 for aggregate statistics
- Laplace noise addition for counts

---

## 10. Implementation Checklist

### 10.1 Pre-Integration

- [ ] Review WIA-ALZHEIMERS specifications (Phase 1-4)
- [ ] Assess current system capabilities
- [ ] Identify integration endpoints
- [ ] Plan data mapping
- [ ] Establish consent workflows

### 10.2 Technical Integration

- [ ] Implement FHIR R5 endpoints
- [ ] Configure HL7v2 interfaces (if needed)
- [ ] Set up OAuth 2.0 authentication
- [ ] Test data exchange with sandbox
- [ ] Validate data transformations

### 10.3 Clinical Integration

- [ ] Train clinical staff on protocols
- [ ] Configure EHR workflows
- [ ] Set up result routing
- [ ] Implement alerting for critical values
- [ ] Establish quality metrics

### 10.4 Certification

- [ ] Complete self-assessment
- [ ] Submit certification application
- [ ] Pass validation testing
- [ ] Complete audit
- [ ] Display certification badge

---

## 11. References

1. HL7 FHIR R5 Specification (2023)
2. IHE Laboratory Testing Workflow (LTW)
3. DICOM Supplement 220: PET Acquisition Context
4. HIPAA Security Rule (45 CFR Part 164)
5. GDPR (Regulation 2016/679)
6. WIA Integration Framework v2.0

---

**弘益人間 (홍익인간) - Benefit All Humanity**

*WIA - World Certification Industry Association*
*© 2025 MIT License*